ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Outcomes of Simultaneous Kidney Pancreas Transplantation in Patients with Type-1 and Type-2 Diabetes Mellitus

H. Shokouh-Amiri1, M. S. Naseer2, S. Badar1, R. McMillan1, D. Aultman1, S. Tandukar1, N. Singh1, G. B. Zibari1

1John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, 2Transplant, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA

Meeting: 2022 American Transplant Congress

Abstract number: 1163

Keywords: Graft failure, Kidney/pancreas transplantation, Metabolic complications, Survival

Topic: Clinical Science » Pancreas » 65 - Pancreas and Islet: All Topics

Session Information

Session Name: Pancreas and Islet: All Topics

Session Type: Poster Abstract

Date: Sunday, June 5, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Advantages for type-2 diabetes mellitus (T2DM) patients receiving simultaneous kidney-pancreas transplantation (SKPT) as compared to kidney transplantation are shorter waiting times and availability of better-quality organs. UNOS approved SKPT for T2DM in 2014. We listed patients with T2DM and ESRD for SKPT with the following criteria: (1) age < 55 years, (2) insulin requirement ≤ 1 unit/kg body weight, (3) BMI ≤ 32 kg/m2. The aim of this study was to measure the change in volume of SPKT and compare outcomes between SKPT T1DM and T2DM recipients.

*Methods: From Feb 2010 to Jul 2021, 62 T1DM and 36 T2DM SKPT recipients were studied. BMI, c-peptide, HbA1c, and e-GFR were evaluated pre-transplant and post-transplant until 1-year. Outcomes included volume of SKPT pre-and post- UNOS approval of SKPT for T2DM, complications, death-censored 5-year kidney and pancreas graft survival, and 5-year patient survival.

*Results: Among 98 SKPT, 18 (T1DM) were done before and 80 (44 T1DM and 36 T2DM) after the UNOS approval of SKPT in T2DM, translating to an increase in SKPT from 3.6/year to 11.4/year (216.7% increase). T2DM patients were older, gained weight post-transplantation, and had higher BMI and e-GFR at 1-year post-transplant (Table 1). There were no differences in complications and graft and patient survival (Figure 1).

*Conclusions: UNOS approval of SKPT for T2DM led to an increase in SKPT with no differences in graft or patient survival between T1DM and T2DM patients. Weight gain should be carefully monitored and managed post-transplant in SKPT T2DM recipients.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Shokouh-Amiri H, Naseer MS, Badar S, McMillan R, Aultman D, Tandukar S, Singh N, Zibari GB. Outcomes of Simultaneous Kidney Pancreas Transplantation in Patients with Type-1 and Type-2 Diabetes Mellitus [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/outcomes-of-simultaneous-kidney-pancreas-transplantation-in-patients-with-type-1-and-type-2-diabetes-mellitus/. Accessed May 9, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences